Clinical Trial Update: A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mepolizumab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) has completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Churg-strauss Syndrome
• Eosinophilic Granulomatosis with Polyangiitis

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Churg-Strauss Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2018-01-26